INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Clinical, Commercial Packaging: Delivering Next-Gen Therapies

  See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

• Collaborative Supply Chain Management In A Fragmented World

  Biopharma supply chains are under pressure. As regionalization accelerates, success depends on agility, trust, and new approaches to collaboration that can withstand ongoing global uncertainty.

• Biopharma Supply, Reimagined: Regional, Resilient Manufacturing

  Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.

• Empowering Patients With Self-Administration Drug Delivery Devices

  Discover how these devices offer solutions to the challenges of precise dosing, patient compliance, retention, and safety, uplifting the overall trial experience and providing real world insights.

• How To Save Significantly On Early-Phase Clinical Supply

  5/6/2026

  Discover how integrated clinical supply strategies streamline early trials, reduce logistics complexity, cut costs, and ensure timely delivery of investigational products and samples.

• Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals

  10/24/2024

  Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

• The Importance Of Quality In Raw Material Selection

  1/16/2025

  Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  6/9/2025

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• Integrated Single-Site CDMO Model

  3/16/2026

  A single‑site model reduces handoff risks, speeds timelines, strengthens quality oversight, and unifies development and manufacturing to improve reliability and execution efficiency.